Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results

ALACHUA, Fla., Dec. 7  /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. (AMEX:TTG), a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, will report financial results for the fourth quarter and fiscal-year 2007 ended September 30, 2007 on Monday, December 10, 2007 at 4:30 p.m. ET.

Interested parties can access the call by dialing [phone] or [phone] or by accessing the web cast at http://www.tutogen.com/investor.aspx. A replay of the call will be available at [phone] or [phone], conference ID number: 19673685 for 3 days following the call, and the web cast can be accessed at http://www.tutogen.com/investor.aspx for 30 days.

About Tutogen Medical, Inc.

Tutogen Medical, Inc. manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its Tutoplast Process(R) of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures. The Company's Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc., Davol Inc. subsidiary of C.R. Bard Inc., the Mentor Corporation (Mentor), Coloplast Corp., IOP, Inc. and through independent distributors internationally. For more information, visit the Company's Web site at http://www.tutogen.com/.

   Contacts:
   L. Robert Johnston, Jr.             Lytham Partners, LLC
   Chief Financial Officer             Joe Diaz
   Tutogen Medical, Inc.               Joe Dorame
   386-462-0402                        Robert Blum
                  602-889-9700


DATASOURCE: Tutogen Medical, Inc.



CONTACT:  L. Robert Johnston, Jr., Chief Financial Officer of Tutogen

Medical, Inc., [phone], ; or Joe Diaz, or Joe

Dorame, or Robert Blum, all of Lytham Partners, LLC, [phone]



Web site:  http://www.tutogen.com/ 

Copyright